SCHEMBL742071

SCHEMBL742071

CC(C)(NC(=O)c1cc2c(NC(=O)c3ccccn3)n[nH]c2s1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.46
ABL1 P00519 2/20 0.46
BCR P11274 2/20 0.46
MAPK1 P28482 1/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
EGLN1 Q9GZT9 3/20 0.40
ANO1 Q5XXA6 1/20 0.39
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
PKM P14618 3/20 0.38
POLB P06746 2/20 0.36
TACR3 P29371 1/20 0.36
GAA P10253 1/20 0.36
PRKCB P05771 1/20 0.36
ALDH1A1 P00352 1/20 0.36
FLT3 P36888 1/20 0.36
KCNK3 O14649 1/20 0.36
KCNK9 Q9NPC2 1/20 0.36
KDR P35968 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL740292 0.88 AURKA (0.55) AURKAABL1BCRNPC1RAB9A
SCHEMBL740809 0.86 AURKA (0.52) AURKAABL1BCRMAPK1KCNK3
SCHEMBL741311 0.85 AURKA (0.53) AURKAABL1BCRNPC1RAB9A
SCHEMBL742901 0.85 ABL1 (0.49) AURKAABL1BCRMAPK1EGLN1
SCHEMBL741044 0.85 AURKA (0.51) AURKAABL1BCREGLN1NPC1
SCHEMBL743308 0.84 AURKA (0.48) AURKAABL1BCRMAPK1NPC1
SCHEMBL4633630 0.84 CA1 (0.48) MAPK1CA1CA2NPC1RAB9A
SCHEMBL1778864 0.84 AURKA (0.41) AURKAABL1BCREGLN1TACR3
SCHEMBL740955 0.84 CDK7 (0.48) AURKAABL1BCRMAPK1POLB
SCHEMBL738866 0.83 AURKA (0.53) AURKAABL1BCRNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed